Medal lecture highlights evolution in radiotherapy treatments for ocular tumours

Radiotherapy has made major advances in recent years in offering a viable treatment modality to patients with ocular tumours that were once deemed inoperable, according to Leonidas Zografos who delivered this year's EURETINA MEDAL LECTURE as part of the official Opening Ceremony at the 13th EURETINA Congress.
In a broad overview of the past, present and future of radiotherapy treatments in ocular oncology, Prof Zografos, honorary professor of ophthalmology and consultant at the Jules-Gonin Eye Hospital Lausanne ,Switzerland, told delegates that technology had come a long way since the pioneering German ophthalmologist Richard Deutschmann's first successful treatment of uveal melanoma in 1915 with seven episcleral applications of filtered mesothorium.
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.